Printer Friendly

BIO-RAD ANNOUNCES SETTLEMENT OF GOVERNMENT CIVIL PROCEEDING

 BIO-RAD ANNOUNCES SETTLEMENT OF GOVERNMENT CIVIL PROCEEDING
 HERCULES, Calif., Oct. 6 /PRNewswire/ -- Bio-Rad Laboratories Inc. (AMEX: BIO-A and BIO-B), announced that it has reached a settlement with the U.S. Department of Justice on an outstanding civil matter concerning product pricing activities by the company's Digilab Division. The company has agreed to pay $1,500,000 in settlement of civil claims made by the General Services Administration (GSA). The full amount of the settlement has been provided for in prior periods and will have no material impact on the financial statements of Bio-Rad.
 As previously reported, the company was served with a subpoena in January 1991 by the GSA requesting materials for the period Dec. 1, 1983, to Jan. 10, 1991, related to various contracts between the company's Digilab Division and the GSA. Management set aside reserves in 1991 and 1992 to provide for potential fines or penalties. Although related criminal charges have been made, management believes settlement of the remaining issues will not have a material impact on the financial position of the company.
 Bio-Rad Laboratories is a multinational manufacturer of research products, clinical diagnostics and analytical instruments based in Hercules.
 -0- 10/6/92
 /CONTACT: James L. Viglienzone, treasurer of Bio-Rad Laboratories, 510-724-7000, ext. 5697/
 (BIO-A BIO-B) CO: Bio-Rad Laboratories Inc.; General Services Administration ST: California IN: MTC SU:


TM -- SF009 -- 7135 10/06/92 14:03 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 6, 1992
Words:230
Previous Article:FIRST FEDERAL SAVINGS BANK OF PUERTO RICO EARNINGS UP 139 PERCENT; HISTORIC RECORD
Next Article:AEROMEXICO JOINS MAXXAM-LED GROUP IN $400 MILLION INVESTMENT OFFER FOR CONTINENTAL AIRLINES
Topics:


Related Articles
BIO-RAD ANNOUNCES SETTLEMENT OF EMINENT DOMAIN ACTION
BIO-RAD LABORATORIES ANNOUNCES SALE OF OPHTHALMIC DIVISION
CAMBRIDGE DISTRIBUTOR CHARGED WITH DEFRAUDING GENERAL SERVICES ADMINISTRATION
BIO-RAD ANNOUNCES RECEIPT OF $2 MILLION GRANT
BIO-RAD REPORTS RECORD RESULTS FOR THE FIRST QUARTER 1996 AND ANNOUNCES STOCK SPLIT
Bio-RAD wins patent suit for HIV-2 test against Genelabs.
Bio-Rad and Immucor Announce French Distribution Agreement.
Bio-Rad and Immucor Announce French Distribution Agreement.
Bio-Rad Files 13D With SEC.
BioSource rebuffs Bio-Rad's unsolicited offer.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters